-+ 0.00%
-+ 0.00%
-+ 0.00%
Zhitong Finance App News, Hehuang Pharmaceutical (00013.HK) issued an announcement. Following the medical insurance renewal with the China National Health Insurance Administration (National Health Insurance Administration), ELUNATE® (ELUNATE®), ORPATHYS® (ORPATYS®), and SULANDA® (SULANDA®) will continue to be included in the new “National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue” (National Medical Insurance Drug Catalogue) effective from January 1, 2027. This update covers the inclusion of new indications, renewal of existing indications, and ongoing coverage under the current multi-year agreement.
Share
Listen to the news
Zhitong Finance App News, Hehuang Pharmaceutical (00013.HK) issued an announcement. Following the medical insurance renewal with the China National Health Insurance Administration (National Health Insurance Administration), ELUNATE® (ELUNATE®), ORPATHYS® (ORPATYS®), and SULANDA® (SULANDA®) will continue to be included in the new “National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue” (National Medical Insurance Drug Catalogue) effective from January 1, 2027. This update covers the inclusion of new indications, renewal of existing indications, and ongoing coverage under the current multi-year agreement.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending